biosimilar

Lupin announces USFDA acceptance for a biosimilar application

Lupin announces USFDA acceptance for a biosimilar application

June 2, 2021

Gland Pharma Q4 results: Net profit rises 34% to Rs 260 cr

Gland Pharma Q4 results: Net profit rises 34% to Rs 260 cr

May 17, 2021

Biocon Q4 results: Biocon Q4 results: Net profit grows 105% on strong biosimilar business growth

Biocon Q4 results: Biocon Q4 results: Net profit grows 105% on strong biosimilar business growth

April 29, 2021

Biocon Share Price: Biocon tanks 4% as USFDA defers decision on Avastin biosimilar application

Biocon Share Price: Biocon tanks 4% as USFDA defers decision on Avastin biosimilar application

December 28, 2020